<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe four cases in which abciximab was used as a thrombolytic rescue agent in the setting of thrombotic events complicating interventional neuroradiologic procedures </plain></SENT>
<SENT sid="1" pm="."><plain>After IV administration of abciximab, the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> resolved within 30 min in three cases, whereas no thrombolysis occurred in the fourth case despite the addition of intraarterial tissue plasminogen activator </plain></SENT>
<SENT sid="2" pm="."><plain>Further evaluation of <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> IIb-IIIa inhibitors in patients with cerebral <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> is necessary to prove clinical efficacy </plain></SENT>
</text></document>